In chronic experiments on five groups of WAG/Rij rats (a genetic model of absence epilepsy; six animals in each group), we recorded EEG activity from the S1po cortical area through implanted electrodes and subjected the cortex to the action of four agents affecting L-and T-type calcium channels (injections through an implanted cannula). A blocker of L-type channels, verapamil hydrochloride, an agonist of these channels, Bay K8644, an antagonist of T-type calcium channels, L-ascorbate, and an agonist of the latter channels, PMA, were used. The parameters of 7-to 10-Hz spike-wave discharges, SWDs, spontaneously generated in the cortex of this rat strain (frequency within SWDs, mean duration of the latter, and their number) were measured within the baseline interval (before injections) and within three subsequent 20-min-long post-injection intervals. Normal saline was injected in the control group. There were no significant differences in the mean peak frequency in SWDs between all examined groups (P > 0.05 in all cases). Verapamil significantly (by more than 40%; P < 0.05) decreased the mean SWD duration throughout the entire period of post-injection observation. The dynamics of the Bay K8644 effects were rather similar, but the intensity of SWD duration changes was somewhat smaller. Both the above agents in the doses used dramatically decreased the number (frequency of appearance) of SWDs within the observation period. L-ascorbate also suppressed SWD generation. The duration of these phenomena decreased mildly, while their number dropped dramatically. In the PMA group, the number of SWDs increased significantly (by 50%, P < 0.05) within the first 20-min-long interval, but this was not observed within subsequent intervals. These findings confirm that blocking or activating of L-and T-type Ca 2+ channels in the S1po area (cortical focus area) can significantly control generation of SWDs during absence seizures. Possible mechanisms underlying actions of the tested agents are discussed.
INTRODUCTION
Absence seizures are believed to be a phenomenon typical of generalized non-convulsive epilepsies. These events are characterized by some general features, like brief unresponsiveness to environmental stimuli and interruption of consciousness. Absence seizures are characterized by symmetric, bilateral, and synchronous 3-Hz spike-wave discharges (SWDs) [1] . In absence epilepsy, abnormal motor activities may not be recognized [2] . The annual incidence rate of absence epilepsy has been estimated to be about 1.2-7.1 per 100,000 in different populations [3] .
Wistar Albino Glaxo Rijswijk (WAG\Rij) rats are described to be a genetic model for absence epilepsy; these animals exhibit 7-to 10-Hz SWDs lasting from 1 to 30 sec [4, 5] . SWDs are not generated during active wakefulness and REM sleep, but they occur in wakefulness with a low level of alertness [6] . Sixteen to twenty discharges per hour are usually recorded [7] . During seizures, WAG/Rij rats remain immobile and twitch their vibrissae and facial muscles [8] . In line with the cortical focus theory and nonlinear association analysis of SWDs, the S1po is the initiation site for SWDs. Seizure activities that were produced in this zone disseminated quickly in other areas of the cortex and thalamus. It was found that injection of ethosuximide into the ventrobasal Role of L-and T-Type Ca 2+ 
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thalamus and RTN demonstrated a low efficacy in suppression of SWDs [9, 10] .
There is strong evidence that entry of Ca 2+ ions into neurons plays a significant role in generation of seizures [11] . Throughout epileptiform activity, intracellular Ca 2+ concentration increases, while extracellular Ca 2+ concentration is reduced [12] . High-and low-voltage-activated (HVA and LVA) calcium channels are involved in the regulation of neuronal excitability and production of absence SWDs. High-voltage-activated calcium channels include different subunits (α, β, , γ, and σ). In mammals, genome expression forms three large families of subtype β1. Four different kinds of L-type HVA calcium channels belong to the Cav1 family (Cav1 through Cav1.4) [13] , Cav1.2, and Cav1.3 channels are located on neuronal membranes, generally on the dendrites [14] . In hippocampal neurons, calcium currents in cells depend mostly on the presence of L-type channels [15] .
Low-voltage-activated T-type channels are monomers of subunit β 1 , and their activation results from relatively small membrane depolarization. Such channels are members of the Ca v 3 family, and they are divided into three groups (Ca v 3.1-Ca v 3.3) [13] . T-type calcium channels play key roles in the regulation of neuronal excitability. Hyperactivity of these channels causes some neurological disorders, such as absence seizures and neuropathic pain [16] . It was mentioned that the activity of T-type channels is increased in a mouse model of epilepsy [17] .
In our study, we examined the role of L-and T-type calcium channels on SWDs recorded from the cortical S1po area in WAG/Rij rats. The experiment addressed an important question of how SWDs can be changed after injections of agents that effectively influence the above-mentioned channels. These are a blocker of L-type calcium channels, verapamil hydrochloride; an L-type channel agonist, Bay K8644 (methyl-1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyridine-5-carboxylate), an antagonist of T-type calcium channels, L-ascorbate; and T-type channel agonist, PMA (phorbol 12-myristate 13-acetate, a protein kinase C activator).
METHODS
Animals and Drugs. Experiments were carried out on 30 WAG/Rij rats (age from 4 to 6 months, body mass from 220 to 260 g). Animals were main tained under standard lab conditions (22 °C, light/dark cycle 12/12 h, and unlimited access to food and water until the presupposed time of the experiment).
Bay K8644, verapamil, and PMA were purchased from Tocris (Great Britain), while L-ascorbate was purchased from Sigma (USA). Verapamil and L-ascorbate were dissolved in 0.9% saline. For injections into the S1po cortex (in the volume of 1 µl), Bay K8644 was dissolved in 0.9% saline and ethanol. To inject 500 nmol PMA, a stock solution containing 2 mM PMA in DMSO was dissolved in saline to the necessary concentration.
Surgical Procedure. Rats were anesthetized i.p. by ketamine (80 mg/kg) and xylazine (5 mg/kg) [18] . All animals were implanted with two cortical stainless steel electrodes for EEG recording and a cannula for drug injection. The coordinates of the cannula tip were the following: 2.1 mm posterior, 5.5 mm lateral to the bregma, and 4.0 mm vertical from the skull surface (according to the stereotaxic atlas [19] ).
The monopolar EEG recording electrode was in the frontal cortical region of the right hemisphere (coordinates: AP = 0.22, L = 0.24, and V = 0.26), while the reference electrode was on the occipital cortex. Electrodes were fixed in the sockets by pins. The cannula socket was fixed to the skull by dental cement.
Recording and Injection. After 1-week recovery from surgery, rats were settled in a Faraday cage, and EEG was recorded from freely moving animals. Spike-wave discharges ( Fig. 1 ) were recorded 20 min before and three times within 20-min-long intervals after drug injections. Mild natural stimuli (moderate sound or touch) were applied to prevent the animal from sleeping. Separate groups of rats were used to characterize the effects of verapamil, Bay K8644, L-ascorbate, and PMA. For bilateral injection of 1 µl of the solution, a 27 G cannula needle in the guide cannula was connected to a 10 µl Hamilton syringe. A dose of 22.4 µmol of Bay K8644 was injected. The verapamil hydrochloride injection dose was 40 µmol. In addition, 500 nmol of PMA and 100 µmol of L-ascorbate were injected in the respective animal groups.
Statistical Analysis. For statistical analyses, SPSS13 software was used. Variables (mean within-SWD peak frequency, mean duration, and number of SWDs) were analyzed by intragroup repeated measures and one-way ANOVA between groups. The Sidok test was applied for post-hoc analysis.
Values were expressed as a percentage with respect to baselines; in intergroup comparisons, P values smaller than 0.05 were considered statistically significant. The baseline was calculated as 100%.
Histological Verification. After euthanizing the animals by a high dose of ketamine, we quickly removed the brains and fixed them in 10% formalin. The locations of the cannula tip were verified by cresyl violet staining in coronal sections of the brain.
RESULTS
To evaluate the effects of Bay K8644, verapamil, L-ascorbate, PMA, and control (saline) injections on SWDs, the mean peak frequency in these events, their mean duration, and number measured within three 20-min-long intervals after injection of the drugs were analyzed. The saline group served as the control. The data were averaged and presented as percentages of the baseline values taken as 100%. During the baseline period, EEG was recorded for 20 min, and the rats did not receive any drugs or saline.
Effects of Verapamil and Bay K8644 on SWDs. The SWD parameters during the above-mentioned 20-min-long periods for Bay K8644, verapamil, and control groups (six rats in each group) were compared using one-way ANOVA. No significant dissimilarities in the mean whithin-SWD peak frequency between experimental groups were found (P < 0.05).
In the control group, the mean SWD duration within the first 20-min-long post-injection interval practically did not differ from the baseline value. Later on, a mild trend toward decrease in this index was observed ( Figs. 2A and 3A) . At the same time, an analogous trend toward decrease in the values of the mean number of SWDs was quite obvious throughout the entire post-injection observation period in the control (saline) group (Figs. 2B and 3B)
Comparison of the groups revealed remarkable effects of the agents on the number and duration of SWDs (P < 0.05). During the first 20-min interval following injection of Bay K8644 and verapamil, the mean duration of SWDs in the Bay K8644 group was smaller than that in the control group (71 ± 13.5% vs 102 ± 14.6%). In the verapamil group compared to the control group, an even greater (56 ± 12.8 % vs 102 ± ± 14.6%) reduction of mean duration in the first 20-min phase was found.
The diference between the mean duration of SWDs in verapamil hydrochloride and control groups during the second and third 20 min was significant (P <0.05). Within the second 20-min phase, the decrease in the SWD duration in the verapamil group was smaller compared to the During the third 20-min interval, there was also a decrease in the mean duration in comparison with the control group (55 ± 7.1 and 89 ± 12.6%; Fig. 2A) .
Injections of Bay K8644 also led to significant decreases in the mean duration of SWDs during the entire 60-min-long period of post-injection observation. The dynamics of changes in this index were rather similar to that in verapamil-injected rats, but the relative intensity of the drops was somewhat smaller (Fig. 2A) .
In verapamil-injected animals, the mean numbers of SWDs were also dramatically smaller than those observed in control animals. The respective figures in the first 20 min were 27 ± 8.51% vs 90 ± 19.9%, in the second 20-min interval they were 14 ± 5.9% vs 78 ± 6.1%, and in the third period they were 12 ± 8.7% and 61 ± 6.7% (Fig. 2B) .
During the first, second, and third 20-min phases, considerable differences in the number of SWDs were also noted between the Bay K8644 and control groups. These were 21 ± 11.0 vs 90 ± 19.9%, 8.0 ± 5.1 vs 78 ± 6.1%, and 5.0 ± 5.1 vs 61 ± 7.0% , respectively (Fig. 2B) .
The results of three experimental groups compared using the repeated measures test showed that, during the first, second and third 20-min-long intervals after injection, there were no significant differences between the values of the mean peak frequency and mean duration of SWDs at these time points (P > 0.05 in all cases).
Effects of L-Ascorbate and PMA on SWDs.
Statistical analyses showed that the mean within SWD peak frequency did not change significantly in the L-ascorbate and PMA groups in comparison with the control group (P > 0.05). During the first 20 min post-injection, there was a noticeable decrease in the mean duration of SWDs in the L-ascorbate group and a mild trend toward increase in this index in the PMA group; the difference between these groups was significant (75 ± 21.0 vs 109 ± 3.6%).
Within the second and third 20-min-long intervals after injections, the mean durations did not show significant differences between the three groups (P > 0.05; Fig. 3A) . The mean number of SWDs during the first 20 min in the PMA group was significantly greater (150 ± ± 17.7%) compared to the control (90 ± 19.9%) and baseline values. Within the subsequent period (second and third intervals of observation), the mean number of SWDs in the PMA group decreased below the baseline value (Fig. 3B) .
Injections of L-ascorbate led to dramatic decreases in the mean number of SWDs within the entire period of 60-min-long post-injection observation. Within the first, second, and third 20-min-long intervals, the respective values were 20 ± 9.2%, 15 ± 7.4%, and 10 ± 8.5%, as compared to the baseline value; all these figures were significantly smaller (P < 0.05) than the respective values in the control group (Fig. 3B) .
All three consequent values of the normalized mean number of SWDs in the L-ascorbate group differed significantly (P < 0.05) from the corresponding values in the PMA group. enters via voltage-dependent calcium channels, like L-and T-type channels, across the plasma membrane and increases the Ca 2+ concentration in excitable cells [20] . Our study was aimed at elucidating the role of the above calcium channels in the regulation of SWDs in WAG/Rij rats with absence seizures. For this purpose, verapamil, Bay K8644, L-ascorbate, and PMA were used. Our observations after microinjections of these drugs into the rat cortex showed that both Bay K8644 and verapamil reduced the mean duration and number of SWDs considerably. Injection of L-ascorbate decreased the number of SWDs, while increases in the mean duration and (especially) in the number of SWDs after receiving of PMA were found within the initial phase of observation.
In contrast to our results, a study on mice reported that when Bay K8644 was injected intracerebroventricularly (i.c.v), this agent produced seizure activity [21] . Furthermore, Bay K8644 increased calcium effects in an in vitro study on rat caudate neurons [22] . It was mentioned that, when introduced in the nucl. accumbens and bed nucl. stria terminalis, Bay K8644 exerted an activating effect on Cav1.3 [23] .
Although Bay K8644 is known as an L-type Ca
2+
channel opener and pro-convulsive drug, it does not exert such an effect in all models [24] . Throughout the convulsion threshold test on mice, Bay K8644 did not demonstrate the above action. In genetically epilepsy-prone rats (GEPR) and DBAr2 mice, this drug could not cut down audiogenic seizures [25, 26] . At the same time, Bay K8644 suppressed SWDs when administrated in a certain dose. In WAG/Rij rats, i.c.v. injections of high concentrations of Bay K8644 initiated convulsions, but administration of lower doses did not cause such an effect. As was reported earlier, administration of an L-type Ca 2+ channel agonist, Bay K8644, suppresses SWDs, but dihydropyridines (L-type Ca 2+ channel blockers) increase SWD incidence [27] . Experiments on rats [28] demonstrated that Bay K8644 suppresses SWDs, but administration of nimidipine (an L-type calcium channel antagonist) exerted a facilitating effect. The effect of Bay K8644 on SWDs in the cited report was also found in our study; thus, these data suggest that seizure activity can be reduced by the L-type Ca 2+ channel activator Bay K8644. As was determined by experiments with administration of β 2 -adrenergic agonists and GABA agonists, Bay K8644 exerts a dual action in epilepsy. In convulsive epilepsy, its action is pro-convulsing, but it demonstrates an antiepileptic activity in nonconvulsive epilepsy. The dual effect of Bay K8644 indicates that the respective mechanisms in convulsive and nonconvulsive epilepsy are different [28] . Verapamil is used in the treatment of hypertension (action on vascular smooth muscles) and epilepsy because it can block L-type Ca 2+ currents in most cell types [29] . As was reported, this calcium channel blocker decreased the seizure frequency in a patient that suffered from refractory partial epilepsy [30] . In patients with the status epilepticus after i.v. administration of verapamil, consciousness was regained; according to EEG, no electrical manifestations of the above status were recognized [31] . Verapamil reduced the rate and duration of burst discharges in CA3 pyramidal cells in hippocampal slices [32] . In investigations on slices of the hippocampus and frontal neocortex, verapamil blocked epileptiform field potentials and paroxysmal depolarization shifts [33] . Verapamil reduces the Ca 2+ level in the cytoplasm and induces repolarization in cells by preventing Ca 2+ entry through calcium channels, influencing transmembrane Na + /Ca 2+ exchange, and activating potassium channels sensitive to intracellular Ca 2+ [34] .
Redox agents, such as L-ascorbate, can change gating of T-type Ca 2+ channels. Ca v 3.2 can be inhibited by ascorbate, but this agent does not have any effect on Ca v 3.1 and Ca v 3.3 T-type channels. Regulation of the neuronal excitability depends on Ca v 3.2 channels; so, ascorbate as a neuromodulator of these channels can be involved in modulation of neuronal firing. Ascorbate modulates T-currents and low-threshold spikes in nRT neurons [35, 36] . In both extra-and intra-cellular brain spaces, ascorbate provides dynamic changes in physiological and pathophysiological situations [37] .
The molecular mechanism that explains the inhibitory effect of L-ascorbate on Ca v 3.2 channels is based on metal-catalyzed oxidation (MCO). During this process, reactive oxygen species (ROSs) produced by ascorbate oxidize a histidine residue in domain I S3-S4 region of the channels. Following oxidation of the C2 position of the histidine imidazole ring and formation of 2-oxohistidine, calcium channels are blocked, and the
